|Articles|April 20, 2021
Liposomal and Nanoparticle Technology
Author(s)Pfizer CentreOne
Specializing in oncology, anti-infective and complex formulations, Pfizer CentreOne provides end to end services from development through to commercial manufacture of sterile dosage forms.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
Industry Outlook 2026: Trends Transitioning from 2025 into 2026
2
Medable Presents AI Agent for Automating Trial Master File Processes at JP Morgan Healthcare Conference
3
Amgen Acquires UK Biotech Dark Blue Therapeutics
4
The Critical Need for Digital Transformation in the Peptide and API Sectors
5